Yüklüyor......
In vivo evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.
A-56619 and A-56620 are two new aryl-fluoroquinolones which are as potent as or more potent than norfloxacin when administered orally and subcutaneously in mouse protection tests against Staphylococcus aureus, Streptococcus pyogenes, and Streptococcus pneumoniae. A-56619 and A-56620 were more potent...
Kaydedildi:
| Asıl Yazarlar: | , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
1986
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC176377/ https://ncbi.nlm.nih.gov/pubmed/3521473 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|